A Clinical Study Finds Pfizer's Dacomitinib Delays The Growth of Lung Cancer Cells Better Than AstraZeneca's Iressa Medicine & Technology Jun 06, 2017 In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
Pharaoh's Curse Unlocked? Scientists Claim To Have Cracked the Mystery of What Killed Over 20 People Who Opened the Tomb of King Tut in 1922
SPACE NASA’s TESS Mission Spots Its First Free-Floating Planet Using ‘Rogue-Hunting’ Concept From Einstein
SPACE ‘Morbid’ Alien Theory: Extraterrestrials Haven’t Contacted Humans As They’re Destroyed by Gamma-Ray Bursts